Prohibits the knowing sale, offer for sale, or delivery of xylazine to persons under the age of 21 and without proof of the intended use for institutional, veterinary, or scientific purposes.
- Chamber
- House
- Introduced
- Jan 9, 2025
- Last action
- Mar 10, 2026 — REFERRED TO CONSUMER PROTECTION
- Session
- 2025-2026
- Momentum
- 78 · High